guanosine-diphosphate and Syndrome

guanosine-diphosphate has been researched along with Syndrome* in 2 studies

Other Studies

2 other study(ies) available for guanosine-diphosphate and Syndrome

ArticleYear
Mutation analysis in Costello syndrome: functional and structural characterization of the HRAS p.Lys117Arg mutation.
    Human mutation, 2008, Volume: 29, Issue:2

    Costello syndrome is a mental retardation syndrome characterized by high birth weight, postnatal growth retardation, coarse face, loose skin, cardiovascular problems, and tumor predisposition. De novo heterozygous missense mutations in HRAS codon 12 and 13 disturbing the intrinsic GTP hydrolysis cause Costello syndrome. We report a patient with typical Costello syndrome and a novel heterozygous missense mutation in codon 117 (c.350A>G, p.Lys117Arg) of the HRAS gene, resulting in constitutive activation of the RAS/MAPK pathway similar to the typical p.Gly12Ser and p.Gly12Ala mutations. Recombinant HRAS p.Lys117Arg demonstrates normal intrinsic GTP hydrolysis and responsiveness to GTPase-activating proteins, but the nucleotide dissociation rate is increased 80-fold. Consistent with the biochemical data, the crystal structure of the p.Lys117Arg mutant indicates an altered interaction pattern of the side chain that is associated with unfavorable nucleotide binding properties. Together, these data show that a RAS mutation that only perturbs guanine nucleotide binding has similar functional consequences as mutations that impair GTP hydrolysis and causes human disease.

    Topics: Abnormalities, Multiple; Arginine; Base Sequence; Cell Line; Cell Proliferation; Child; Child, Preschool; Codon; DNA Mutational Analysis; Guanosine Diphosphate; Humans; Hydrolysis; Infant; Infant, Newborn; Lysine; Molecular Sequence Data; Mutant Proteins; Mutation; Proto-Oncogene Proteins p21(ras); Syndrome

2008
Biochemical and functional characterization of Rab27a mutations occurring in Griscelli syndrome patients.
    Blood, 2003, Apr-01, Volume: 101, Issue:7

    Rab27a is a member of the Rab family of small GTPase proteins, and thus far is the first member to be associated with a human disease (ie, the Griscelli syndrome type 2). Mutations in the Rab27a gene cause pigment as well as cytotoxic granule transport defects, accounting for the partial albinism and severe immune disorder characteristics of this syndrome. So far, 3 Rab27a missense mutations have been identified. They open a unique opportunity to designate critical structural and functional residues of Rab proteins. We show here that the introduction of a proline residue in the alpha 4 (Ala152Pro) or beta 5 (Leu130Pro) loop, observed in 2 of these spontaneous mutants, dramatically affects both guanosine triphosphate (GTP) and guanosine diphosphate (GDP) nucleotide-binding activity of Rab27a, probably by disrupting protein folding. The third mutant, Trp73Gly, is located within an invariant hydrophobic triad at the switch interface, and was previously shown in active Rab3A to mediate rabphilin3A effector interaction. Trp73Gly is shown to display the same nucleotide-binding and GTPase characteristics as the constitutively active mutant Gln78Leu. However, in contrast to Gln78Leu, Trp73Gly mutant construct neither interacts with the Rab27a effector melanophilin nor modifies melanosome distribution and cytotoxic granule exocytosis. Substitutions introduced at the 73 position, including the leucine residue present in Ras, did not restore Rab27a protein functions. Taken together, our results characterize new critical residues of Rab proteins, and identify the Trp73 residue of Rab27a as a key position for interaction with the specific effectors of Rab27a, both in melanocytes and cytotoxic cells.

    Topics: Albinism; Amino Acid Substitution; Animals; Cell Degranulation; Cell Line; Guanosine Diphosphate; Guanosine Triphosphate; Humans; Immunologic Deficiency Syndromes; Melanocytes; Melanosomes; Mice; Mutation; Protein Binding; rab GTP-Binding Proteins; rab27 GTP-Binding Proteins; Syndrome

2003